Navigation Links
ARx(TM) Opens New Pharmaceutical Manufacturing Facility
Date:9/19/2007

Company Expanding to Meet the Global Demands for Innovative Drug Delivery

Systems

GLEN ROCK, Pa., Sept. 19 /PRNewswire/ -- ARx(TM), LLC, a subsidiary of Adhesives Research, is pleased to announce the official opening of its new state-of-the-art pharmaceutical manufacturing facility just eighteen months after breaking ground.

The new 25,000 square-foot facility is designed to manufacture dissolvable film, transdermal, and buccal drug delivery systems for over-the-counter (OTC), prescription, and biopharmaceutical products. The globally-compliant facility triples ARx's manufacturing capacity and laboratory space to support its rapidly growing portfolio of projects and clients.

ARx currently supports multiple commercial thin film products sold in the United States, Canada and Latin America, including Novartis Consumer Health's Triaminic(R) Thin Strips(TM) pediatric and infant cough and cold products, Theraflu(R) Thin Strips(TM) cold and flu products, and Gas-X(R) Thin Strips(TM) anti-gas relief products. The current facility and evolving pipeline further supports ARx's market leadership by quadrupling potential strip output to over 1.4 billion strips per year.

"We have used our knowledge and twenty-plus years of experience in the pharmaceutical industry to build a modern, globally-compliant facility that allows us to streamline the manufacturing process and create an efficient and flexible process for our clients," said Beth Vondrak, ARx Vice President and General Manager.

Dissolvable thin film technology gives consumers a choice of delivery options for taking OTC and prescription medicines. The key benefits of the technology include quick and precise dosing, convenience and portability. These films have proven to be very popular for the pediatric population, who usually ingest the entire thin film dose (versus liquids that can be expelled from the mouth), as well as with geriatric patients and other individuals who have difficulty swallowing pills and those who prefer on-the-go relief.

ARx, a subsidiary of Adhesives Research, was created in 2005 to address the growing global need for innovative delivery of active drug-containing systems and is a custom developer and supplier of high-quality drug and biopharmaceutical delivery materials and technologies for the pharmaceutical industry. Adhesives Research has over 20 years of experience in providing unique components for transdermal, oral and topical drug delivery. The new facility brings the total square footage at the company's corporate headquarters to more than 240,000 square feet.

For more information on ARx and Adhesives Research, please call 717-235-7979 (1-800-445-6240) or visit http://www.adhesivesresearch.com.


'/>"/>
SOURCE ARx, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First global SARS meet opens
2. Cancer Drug Opens Arteries
3. Ranbaxy opens Drug discovery centre in Gurgaon
4. Delhi Hospital Opens Up Avenues For Computer-Aided Knee Replacement
5. Cancer Hospice Opens New In-patient Unit
6. Center for Celiac Disease Opens
7. Review Opens Bag of Tricks for Reducing Pain from Children’s Shot
8. Apollo Eyes Expansion in Kolkata, Opens Ayurveda Clinic
9. Largest Ever African HIV Vaccine Trial Opens in South Africa
10. Apollo Opens Blood Cancer Clinic in Kolkata
11. China Opens Doors For Foreign Investments In Hospitals Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of ... pain with a reputable physician in their area, announces the launch of a new ... for patients who are looking for reputable physicians to help them with back or ...
(Date:4/25/2017)... NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed ... treatment of acute or chronic problems, I focus on preventative care with all my patients ... you have any questions, always feel free to contact my office and my trained staff ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Uro/Gyn and Gynecology markets with innovative and proprietary products, ... March 31, 2017 after the market close on Tuesday, ... host a conference call and webcast to discuss its ... 2017 at 4:30 p.m. Eastern Time (3:30 p.m. Central ...
Breaking Medicine Technology: